NCT00619060 is a Phase 1 clinical trial of Topical Myristyl Nicotinate Cream in Healthy, sponsored by University of Arizona.

Who is sponsoring NCT00619060?

NCT00619060 is sponsored by University of Arizona.

What drugs are being tested in NCT00619060?

Interventions in NCT00619060: Topical Myristyl Nicotinate Cream, Placebo.

Is NCT00619060 still recruiting?

NCT00619060 is currently completed. Last updated 9 March 2016.

Are results published for NCT00619060?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2016-03-09 · How we verify

NCT00619060

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Phase I Study of Topical Myristyl Nicotinate Cream on Human Skin in Healthy Volunteers

Completed Phase 1 Results posted Last updated 9 March 2016

What this trial tests

Phase 1 trial testing Topical Myristyl Nicotinate Cream in Healthy in 22 participants. Completed in 1 July 2008.

Timeline

1 August 2007

Primary endpoint
1 July 2008

1 July 2008

Quick facts

Lead sponsor	University of Arizona
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	22
Start date	1 August 2007
Primary completion	1 July 2008
Estimated completion	1 July 2008
Sites	1 location across United States

Drugs / interventions tested

Topical Myristyl Nicotinate Cream — full drug profile →
Placebo

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of Arizona

Who can join

18 and older, any sex, with Healthy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Participants With Adverse Events by Treatment.
Time frame: 30 Days
Comparison of number of participants with adverse events by treatment.

Sponsor's own description

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of topical myristyl nicotinate cream may stop skin cancer from forming. PURPOSE: This randomized phase I trial is studying the side effects and best way to give topical myristyl nicotinate cream on the skin of healthy volunteers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence.
Djavid AR, Stonesifer C, Fullerton BT, Wang SW, et al · · 2021 · cited 14× · PMID 34638397 · DOI 10.3390/cancers13194914

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Arizona trials

Trials by the same sponsor.

NCT04062890 — Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance · Phase 2 · withdrawn
NCT05569486 — Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain · NA · not yet recruiting
NCT05064111 — Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy · suspended
NCT06567899 — Mechanistic Underpinnings of Preeclampsia · not yet recruiting
NCT07254793 — Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00619060 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Arizona
Last refreshed: 9 March 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00619060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing